Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802048

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802048

Global Autotransfusion Systems Market Size Study & Forecast, by Product Type, Application, End User and Regional Forecasts 2025-2035

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Autotransfusion Systems Market is valued at approximately USD 0.30 billion in 2024 and is anticipated to grow with a robust CAGR of 6.60% during the forecast period 2025-2035. Autotransfusion systems, designed to collect and reinfuse a patient's own blood during or after surgery, have transformed surgical care by reducing the dependence on donor blood and minimizing the risks associated with transfusion-transmitted infections. With the increasing prevalence of complex cardiovascular and orthopedic procedures, alongside the rising emphasis on patient safety and cost-effectiveness, the adoption of autotransfusion devices is steadily gaining ground. Moreover, a broader healthcare shift toward advanced blood management strategies has played a pivotal role in propelling this market forward.

The increasing incidence of trauma cases, rising frequency of surgeries worldwide, and mounting awareness regarding the benefits of autologous blood transfusion have further fueled demand for these systems. According to the World Health Organization, an estimated 234 million major surgical procedures are performed globally each year, and with rising life expectancy and lifestyle-driven chronic diseases, the surgical volume is expected to continue escalating. This trend, paired with advancements in dual-mode autotransfusion systems that integrate intraoperative and postoperative functionalities, has unlocked significant opportunities for hospitals and specialty clinics to enhance patient outcomes while optimizing operational efficiency. Nevertheless, the relatively high equipment costs and limited accessibility in underdeveloped regions may restrict widespread adoption, particularly in resource-constrained healthcare systems.

From a geographical perspective, North America currently dominates the global landscape, benefiting from its advanced healthcare infrastructure, early adoption of blood management technologies, and strong presence of leading medical device companies. Europe, driven by favorable reimbursement structures, high surgical volumes, and stringent regulatory emphasis on patient safety, represents another critical hub for growth. Meanwhile, Asia Pacific is projected to experience the fastest expansion during 2025-2035, attributed to rapid healthcare modernization, growing surgical burden, and increased government investment in advanced medical technologies across countries such as China, India, and Japan. Latin America and the Middle East & Africa, though relatively smaller markets, are witnessing a steady uptake as hospitals in these regions strive to reduce donor blood dependency and improve transfusion safety standards.

Major market players included in this report are:

  • Medtronic plc
  • Haemonetics Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • LivaNova PLC
  • Stryker Corporation
  • Terumo Corporation
  • Becton, Dickinson and Company (BD)
  • Johnson & Johnson (Ethicon, Inc.)
  • Zimmer Biomet Holdings, Inc.
  • Baxter International Inc.
  • Beijing Jingjing Medical Equipment Co., Ltd.
  • SARSTEDT AG & Co. KG
  • Atrium Medical Corporation
  • Medivators Inc. (Cantel Medical)
  • Shandong Weigao Group Medical Polymer Company Limited

Global Autotransfusion Systems Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product Type:

  • Autotransfusion Systems
    • Intraoperative
    • Post-operative
    • Dual-Mode
  • Consumables & Accessories

By Application:

  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Obstetrics & Gynecological Surgeries
  • Others

By End User:

  • Hospitals
  • Specialty Clinics & Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Autotransfusion Systems Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. key Findings

Chapter 3. Global Autotransfusion Systems Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Autotransfusion Systems Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. Rising surgical volumes and emphasis on patient blood management reducing reliance on allogeneic transfusions
    • 3.2.2. Technological advances in dual-mode (intra/post-operative) systems and growing focus on transfusion safety & cost efficiency
  • 3.3. Restraints
    • 3.3.1. High capital and consumable costs with limited access in resource-constrained settings
    • 3.3.2. Interoperability, training gaps, and clinical hesitancy in select procedures (e.g., contamination risk)
  • 3.4. Opportunities
    • 3.4.1. Fast-growing adoption across APAC, Latin America, and MEA through hospital modernization initiatives
    • 3.4.2. Integration with digital OR workflows, closed-loop automation, and expansion into trauma & OB/GYN use cases

Chapter 4. Global Autotransfusion Systems Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Autotransfusion Systems Market Size & Forecasts by Product Type 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Autotransfusion Systems Market Performance - Potential Analysis (2025)
  • 5.3. Autotransfusion Systems (Intraoperative, Post-operative, Dual-Mode)
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. Consumables & Accessories
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Autotransfusion Systems Market Size & Forecasts by Application 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Autotransfusion Systems Market Performance - Potential Analysis (2025)
  • 6.3. Cardiovascular Surgeries
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Orthopedic Surgeries
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035
  • 6.5. Neurological Surgeries
    • 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.5.2. Market size analysis, by region, 2025-2035
  • 6.6. Obstetrics & Gynecological Surgeries
    • 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.6.2. Market size analysis, by region, 2025-2035
  • 6.7. Others
    • 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.7.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Autotransfusion Systems Market Size & Forecasts by Region 2025-2035

  • 7.1. Autotransfusion Systems Market, Regional Market Snapshot
  • 7.2. Top Leading & Emerging Countries
  • 7.3. North America Autotransfusion Systems Market
    • 7.3.1. U.S. Autotransfusion Systems Market
      • 7.3.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.3.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.3.2. Canada Autotransfusion Systems Market
      • 7.3.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.3.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.4. Europe Autotransfusion Systems Market
    • 7.4.1. UK Autotransfusion Systems Market
      • 7.4.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.4.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.2. Germany Autotransfusion Systems Market
      • 7.4.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.4.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.3. France Autotransfusion Systems Market
      • 7.4.3.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.4.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.4. Spain Autotransfusion Systems Market
      • 7.4.4.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.4.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.5. Italy Autotransfusion Systems Market
      • 7.4.5.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.4.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.6. Rest of Europe Autotransfusion Systems Market
      • 7.4.6.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.4.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.5. Asia Pacific Autotransfusion Systems Market
    • 7.5.1. China Autotransfusion Systems Market
      • 7.5.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.5.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.2. India Autotransfusion Systems Market
      • 7.5.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.5.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.3. Japan Autotransfusion Systems Market
      • 7.5.3.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.5.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.4. Australia Autotransfusion Systems Market
      • 7.5.4.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.5.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.5. South Korea Autotransfusion Systems Market
      • 7.5.5.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.5.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.6. Rest of APAC Autotransfusion Systems Market
      • 7.5.6.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.5.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.6. Latin America Autotransfusion Systems Market
    • 7.6.1. Brazil Autotransfusion Systems Market
      • 7.6.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.6.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.6.2. Mexico Autotransfusion Systems Market
      • 7.6.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.6.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.7. Middle East and Africa Autotransfusion Systems Market
    • 7.7.1. UAE Autotransfusion Systems Market
      • 7.7.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.7.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.2. Saudi Arabia (KSA) Autotransfusion Systems Market
      • 7.7.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.7.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.3. South Africa Autotransfusion Systems Market
      • 7.7.3.1. Product Type breakdown size & forecasts, 2025-2035
      • 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Medtronic plc
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Financial Performance (Subject to Data Availability)
    • 8.2.5. Product/Services Port
    • 8.2.6. Recent Development
    • 8.2.7. Market Strategies
    • 8.2.8. SWOT Analysis
  • 8.3. Haemonetics Corporation
  • 8.4. Fresenius Medical Care AG & Co. KGaA
  • 8.5. LivaNova PLC
  • 8.6. Stryker Corporation
  • 8.7. Terumo Corporation
  • 8.8. Becton, Dickinson and Company (BD)
  • 8.9. Johnson & Johnson (Ethicon, Inc.)
  • 8.10. Zimmer Biomet Holdings, Inc.
  • 8.11. Baxter International Inc.
  • 8.12. Beijing Jingjing Medical Equipment Co., Ltd.
  • 8.13. SARSTEDT AG & Co. KG
  • 8.14. Atrium Medical Corporation
  • 8.15. Medivators Inc. (Cantel Medical)
  • 8.16. Shandong Weigao Group Medical Polymer Company Limited
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!